Diatreme Resources Limited (DRX) AI Stock Analysis

• Market Cap: AU$90.15M
• Dividend Yield: N/A
• Average Volume (3M): 1.23M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.01
• Revenue Growth: N/A
• EPS Growth: -100.00%
• Country: AU
• Employees: 5
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Industrial Materials
• EPS (TTM): N/A
• Shares Outstanding: 5,008,281,700
• 10 Day Avg. Volume: 2,234,875
• 30 Day Avg. Volume: 1,228,114
• PEG Ratio: 0.64
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -39.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: AU$0.02 ▼(-15.00% Downside)
• Action: Reiterated Date: 03/14/26
• Date: Action: Reiterated 03/14/26

The score is held back primarily by weak and unstable operating performance with persistent cash burn, despite a strong low-leverage balance sheet. Technical signals add risk (extremely overbought momentum readings alongside a price below key moving averages), and valuation is difficult to support due to negative earnings and no dividend.

Positive Factors

Low leverage / strong balance sheet

Consistently low debt and a sizable equity base materially reduce financial risk for a development-stage miner. This balance-sheet strength provides flexibility to fund exploration, support permitting and feasibility work, and negotiate joint ventures without immediate solvency pressure.

Stable/growing assets and equity cushion

Growing and stable asset/equity levels create a tangible funding cushion for advancing silica projects. That structural buffer supports multi-stage development timelines and can make the company a more credible partner for offtakes, farm-outs, or project-level financing.

Clear industry focus on silica sands for industrial markets

A defined strategy targeting high-purity silica for established industrial end-markets (e.g., glass) aligns the company with durable industrial demand. This focus improves the odds of securing offtake or JV partners if projects reach development, supporting long-term revenue pathways.

Negative Factors

Persistent negative operating cash flow

Chronic operating cash burn signals ongoing dependency on external financing to fund exploration and development. Over months to years this raises dilution risk, constrains discretionary spending, and may delay project milestones if capital markets tighten or funding terms worsen.

Tiny, volatile revenue; zero revenue in 2025

Irregular or nonexistent revenue prevents meaningful operating leverage and makes project economics unproven. Without demonstrable sales, forecasting cash generation and securing long-term contracts or financing is harder, increasing execution risk over the next several quarters.

Inconsistent profitability and recurring operating losses

Recurrent operating losses indicate the core exploration/development activity hasn't delivered sustainable margins. Reported profits in some years appear non-operating; investors and partners need recurring positive operating performance to justify scale-up or final investment decisions.

Diatreme Resources Limited Business Overview & Revenue Model

Company Description

Diatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. The company's flagship property is the Galalar Silica Sand project located in North Queensland. Diatreme Resources Limited was incorporated in 1993 and is based in Coorparoo, Australia.

How the Company Makes Money

Diatreme Resources’ primary pathway to generating revenue is through the development and potential operation (or monetization) of silica sand projects. If a project reaches production, revenue would typically be earned from selling extracted and processed silica sand under offtake or sales contracts to industrial customers (e.g., glass and related manufacturers), with cash flows driven by sales volumes and realized prices, net of mining, processing, logistics, and regulatory compliance costs. As an exploration/development-stage company, it may also generate value and potential funding by progressing projects through permitting, feasibility studies, and resource definition and then monetizing those assets via project-level joint ventures, farm-outs, asset sales, or other strategic transactions; however, specific revenue streams, operating cash flows, customer/offtake arrangements, and partnerships for DRX are null.

Diatreme Resources Limited Financial Statement Overview

Summary

Balance sheet strength (low leverage and stable equity base) is a clear positive, but it is outweighed by very weak operating quality: revenue is tiny/volatile (including zero revenue in 2025 annual), operating profitability is inconsistent with recurring operating losses, and cash flow is persistently negative with ongoing free-cash-flow burn.

Income Statement

Revenue remains very small and volatile, including a drop to zero in 2025 (annual) after 2024 growth, which undermines visibility and operating leverage. Profitability is inconsistent: while 2022–2023 show large net profits, operating results are weak with recurring operating losses (negative EBIT in most years and negative EBITDA in 2024–2025), suggesting reported profits were likely non-operating in nature. Overall, the income profile looks early-stage and unstable with limited evidence of durable core earnings power.

Balance Sheet

The balance sheet is a clear strength: debt is low relative to equity (roughly 1%–7% debt-to-equity across the period), and equity is sizable versus total assets, indicating limited leverage risk. Assets and equity are relatively stable and have grown versus earlier years, providing a cushion to fund development. The main weakness is that returns on equity swing meaningfully (positive in 2022–2023, negative in 2024), reflecting earnings volatility rather than balance-sheet stress.

Cash Flow

Cash generation is the key weakness: operating cash flow is negative every year shown, and free cash flow is consistently negative, with a notable deterioration in 2024 and still deeply negative in 2025 (annual). Free cash flow growth is also highly volatile, pointing to uneven spending and/or funding needs. While the company can potentially rely on its low leverage, the ongoing cash burn implies continued dependence on external financing unless operations improve materially.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	0.00	886.46K	468.51K	110.14K	23.94K
Gross Profit	-306.60K	886.46K	254.29K	-61.14K	-77.02K
EBITDA	-3.00M	-4.61M	10.70M	-2.94M	-1.94M
Net Income	-744.96K	-439.53K	10.37M	4.98M	-2.15M
Balance Sheet
Total Assets	94.51M	95.45M	66.53M	55.33M	33.14M
Cash, Cash Equivalents and Short-Term Investments	2.34M	5.19M	10.77M	13.64M	6.50M
Total Debt	1.05M	1.20M	1.75M	1.54M	1.61M
Total Liabilities	2.23M	2.51M	2.96M	2.59M	2.37M
Stockholders Equity	92.28M	92.94M	63.57M	52.75M	30.76M
Cash Flow
Free Cash Flow	-2.40M	-7.71M	-2.80M	-9.57M	-8.70M
Operating Cash Flow	-2.39M	-6.00M	-2.32M	-2.51M	-2.15M
Investing Cash Flow	-549.08K	1.06M	-462.49K	-6.95M	-6.57M
Financing Cash Flow	92.22K	-643.79K	-86.47K	16.60M	9.43M

Diatreme Resources Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Neutral
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 300.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.

Diatreme Resources Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
EQR	50 Neutral	AU$1.33B	-12.21	-33.71%	―	149.43%	1.20%
A1G	49 Neutral	AU$484.29M	-1,529.11	-22.54%	―	―	―
DRX	47 Neutral	AU$90.15M	-127.74	-0.41%	―	―	-100.00%
ASM	47 Neutral	AU$391.29M	-3.48	-10.21%	―	2.00%	8.82%
FHE	47 Neutral	AU$109.70M	-23.96	-23.79%	―	―	-280.00%
ESR	45 Neutral	AU$72.95M	-48.11	-9.09%	―	―	35.29%

Diatreme Resources Limited Corporate Events

Diatreme Resources Releases 2025 Annual Financial Statements

Diatreme Resources Limited has released its annual financial statements for the year ended 31 December 2025, including the directors’ report, audited consolidated financial statements, and related disclosures. The publication of these results provides investors and other stakeholders with a detailed view of the company’s financial performance, position, and governance over the period, forming the basis for assessing its operational resilience and strategic outlook.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Bolsters Cash Position and JV Funding After Clermont Sale and R&D Rebate

Diatreme Resources has strengthened its financial position in the December 2025 quarter through the sale of its Clermont Copper/Gold Project to newly listed Moonlight Resources, in which it now holds a 16.76% stake. The transaction delivered $3.25 million in Moonlight shares and $250,000 in cash, while the company also received an R&D tax incentive refund of $226,894 related to its Cyclone Zircon Project and plans further claims for 2025 expenditure. Diatreme reported total cash and liquid assets of $7.7 million at 31 December 2025, including $5.4 million held within its silica project joint venture, providing additional funding runway as it advances its mineral sands and silica initiatives and continues investor engagement, including a CEO presentation at the Noosa Mining Investor Conference.

The most recent analyst rating on (AU:DRX) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Advances Northern Silica Project with DEIS Submission

Diatreme Resources Limited has submitted the Draft Environmental Impact Statement (DEIS) for its Northern Silica Project to Queensland’s Office of the Coordinator-General. This submission marks a significant milestone in the project’s approval process, highlighting its potential to deliver economic benefits and support the clean energy transition. The DEIS, prepared after extensive investigations, outlines the project’s scope, potential impacts, and mitigation strategies, paving the way for public consultation and review in 2026. The project promises new employment and investment opportunities for the Hope Vale/Cooktown region while managing environmental and cultural impacts.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.